CGEM Cullinan Therapeutics, Inc.

Fundamentals / CIK 0001789972 / USD

Cullinan Therapeutics, Inc. reported $322.6M in total assets and a net loss of $203.5M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CGEM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$132.8M$66.42M$0-$215.0MFY 2020 Revenue: $0FY 2020 Net Income: -$51.80M2020FY 2021 Revenue: $18.94MFY 2021 Net Income: -$65.57M2021FY 2022 Revenue: $0FY 2022 Net Income: $111.2M2022FY 2023 Net Income: -$153.2M2023FY 2024 Net Income: -$167.4M2024FY 2025 Net Income: -$219.9M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $0 $18.94M $0
Research & Development $187.4M $142.9M $148.2M $91.95M $57.75M $43.21M
Total Operating Expenses $241.6M $196.9M $190.6M $132.1M $86.90M $60.34M
Operating Income -$241.6M -$196.9M -$191.1M $144.6M -$67.95M -$60.34M
EBITDA -$241.3M -$196.6M -$190.8M $144.7M -$67.90M -$60.27M
Interest Income $22.21M $29.66M $21.63M $6.61M $477K $888K
Income Before Tax -$219.9M -$167.5M -$169.2M $151.3M -$67.48M --
Income Tax Expense $0 $117K -$14.12M $42.12M $0 --
Net Income -$219.9M -$167.4M -$153.2M $111.2M -$65.57M -$51.80M
Basic EPS -- -- -$3.69 $2.46 -$1.52 -$2.60
Diluted EPS -- -- -$3.69 $2.38 -$1.52 -$2.60
Basic Shares Outstanding -- -- 41.5M 45.2M 43.1M 19.9M
Diluted Shares Outstanding -- -- 41.5M 46.6M 43.1M 19.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $40.17M $44.44M $42.12M $42.95M $41.97M $61.03M $41.46M $40.49M
Total Operating Expenses $52.60M $57.25M $53.70M $55.26M $55.59M $75.80M $55.00M $55.05M
Operating Income -$52.60M -$57.25M -$53.70M -$55.26M -$55.59M -$75.80M -$55.00M -$55.05M
EBITDA -$52.55M -$57.17M -$53.62M -$55.18M -$55.52M -$75.72M -$54.92M -$54.97M
Interest Income $3.29M $3.65M $4.10M $4.62M $5.09M $5.92M $6.58M $7.51M
Net Income -$49.39M -$53.70M -$49.66M -$50.71M -$50.61M -$70.06M -$48.50M -$47.65M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $88.33M $83.00M $98.43M $156.2M $59.77M $168.2M
Short-Term Investments $289.6M $316.0M $368.6M $311.1M $230.7M $42.01M
Cash & Short-Term Investments $377.9M $399.0M $467.1M $467.3M $290.5M $210.2M
Other Current Assets -- -- $3.90M -- -- --
Total Current Assets $386.8M $414.7M $480.2M $474.5M $296.6M $212.3M
Property, Plant & Equipment, Net $421K $683K $989K $1.17M $77K $130K
Long-Term Investments $58.27M $204.4M $0 $80.88M $140.4M $0
Other Non-Current Assets $297K $366K $459K $459K $147K $2.30M
Total Non-Current Assets $61.62M $207.2M $3.99M $86.64M $140.6M $2.43M
Total Assets $448.4M $621.8M $484.2M $561.1M $437.2M $214.7M
Accounts Payable $841K $1.68M $2.49M $2.66M $3.17M $9.68M
Other Current Liabilities $996K $1.44M $914K $1.96M $973K --
Total Current Liabilities $37.74M $30.65M $28.14M $22.50M $11.75M $14.32M
Total Non-Current Liabilities $1.90M $849K $2.15M $3.59M $65K $74K
Total Liabilities $39.64M $31.50M $30.29M $26.09M $11.81M $14.39M
Total Debt (incl. Leases) $2.68M $2.15M $3.59M $5.01M -- --
Common Stock $6.0K $6.0K $4.0K $5.0K $4.0K $3.0K
Retained Earnings -$588.1M -$368.2M -$200.9M -$47.70M -$158.9M -$93.34M
Accumulated Other Comp. Income $1.02M -$133K -$129K -$2.60M -$838K -$2.0K
Total Stockholders' Equity $408.7M $590.3M $453.7M $535.0M $425.0M $199.0M
Total Equity $408.7M $590.3M $453.9M $535.0M $425.4M $200.3M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $88.26M $78.64M $75.08M $88.33M $103.3M $72.82M $76.66M $83.00M
Short-Term Investments $201.3M $255.9M $276.8M $289.6M $229.3M $192.7M $227.2M $316.0M
Cash & Short-Term Investments $289.6M $334.5M $351.9M $377.9M $332.6M $265.5M $303.8M $399.0M
Total Current Assets $298.2M $342.0M $361.4M $386.8M $342.2M $275.9M $317.8M $414.7M
Property, Plant & Equipment, Net $210K $263K $342K $421K $489K $569K $607K $683K
Long-Term Investments $21.90M $19.02M $38.50M $58.27M $140.0M $242.3M $259.4M $204.4M
Other Non-Current Assets $297K $297K $297K $297K $361K $367K $366K $366K
Total Non-Current Assets $24.41M $21.81M $41.58M $61.62M $141.9M $244.4M $261.9M $207.2M
Total Assets $322.6M $363.8M $403.0M $448.4M $484.1M $520.3M $579.7M $621.8M
Accounts Payable $1.14M $3.73M $2.51M $841K $1.72M $2.46M $3.40M $1.68M
Other Current Liabilities $1.47M $1.53M $1.35M $996K $1.51M $2.23M $2.79M $1.44M
Total Current Liabilities $40.13M $40.63M $35.15M $37.74M $32.76M $28.06M $27.35M $30.65M
Total Non-Current Liabilities $1.15M $1.41M $1.66M $1.90M $0 $125K $493K $849K
Total Liabilities $41.27M $42.03M $36.81M $39.64M $32.76M $28.18M $27.84M $31.50M
Total Debt (incl. Leases) $2.00M $2.07M $2.38M $2.68M $1.19M $1.52M $1.84M $2.15M
Common Stock $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K
Retained Earnings -$740.9M -$691.5M -$637.8M -$588.1M -$537.4M -$486.8M -$416.7M -$368.2M
Accumulated Other Comp. Income -$652K -$134K $127K $1.02M $973K $607K $505K -$133K
Total Stockholders' Equity -- -- -- $408.7M $451.4M $492.1M $551.8M $590.3M
Total Equity $281.3M $321.8M $366.2M $408.7M $451.4M $492.1M $551.8M $590.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$219.9M -$167.6M -$155.1M $109.2M -$67.48M -$59.46M
Depreciation & Amortization $311K $306K $310K $93K $53K $62K
Stock-Based Compensation $36.04M $37.82M $30.44M $27.96M $24.38M $14.91M
Change in Payables -$839K -$812K -$167K -$509K -$4.83M $5.58M
Operating Cash Flow -$175.8M -$145.3M -$134.3M -$126.7M -$43.43M -$29.77M
Capital Expenditure -$49K $0 -$208K -$1.13M $0 -$10K
Free Cash Flow -$175.8M -$145.3M -$134.5M -$127.8M -$43.43M -$29.78M
Acquisitions, Net -- -- -- -- -- $1.45M
Purchases of Investments -$236.5M -$721.1M -$373.4M -$377.9M -$525.8M -$69.76M
Investing Cash Flow $180.0M -$136.3M $35.81M $249.0M -$333.8M -$5.42M
Common Stock Issued $0 $262.7M $38.39M $0 $3.28M $145.4M
Share Repurchases -- -- -- -- -- -$6.57M
Financing Cash Flow $1.09M $266.2M $40.75M -$25.93M $268.8M $140.1M
Net Change in Cash $5.33M -$15.43M -$57.72M $96.38M -$108.4M $104.9M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$49.39M -$53.70M -$49.66M -$50.71M -$50.61M -$70.06M -$48.50M -$47.65M
Depreciation & Amortization $53K $79K $79K $79K $79K $77K $76K $77K
Stock-Based Compensation $8.37M $8.45M $7.62M $7.31M $9.47M $9.89M $9.37M $9.63M
Change in Payables -$2.59M $1.22M $1.67M -$879K -$739K -$941K $1.72M -$434K
Operating Cash Flow -$43.08M -$38.22M -$46.05M -$38.11M -$36.88M -$57.61M -$43.16M -$36.63M
Capital Expenditure -- -- -- -- -- -- -- $0
Free Cash Flow -- -- -- -- -- -- -- -$36.63M
Purchases of Investments -$34.40M -$14.57M -$20.14M -$19.60M -$12.57M -$78.53M -$125.8M -$168.0M
Investing Cash Flow $51.64M $40.68M $32.41M $22.39M $67.39M $53.40M $36.80M $15.96M
Financing Cash Flow $1.06M $1.10M $380K $715K $0 $373K $0 $1.58M
Net Change in Cash $9.62M $3.56M -$13.25M -$15.00M $30.52M -$3.83M -$6.35M -$19.08M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -- -358.7% --
Net Profit Margin -- -- -- -- -346.1% --
Return on Equity (ROE) -53.8% -28.4% -33.8% 20.8% -15.4% -26.0%
Return on Assets (ROA) -49.0% -26.9% -31.6% 19.8% -15.0% -24.1%
Current Ratio 10.25x 13.53x 17.07x 21.09x 25.25x 14.82x
Quick Ratio 10.01x 13.02x 16.60x 20.77x 24.73x 14.68x
Debt to Equity 0.01x 0.00x 0.01x 0.01x -- --
Revenue Growth (YoY) -- -- -- -100.0% -- --
Operating Income Growth (YoY) -- -- -232.1% -- -- --
Net Income Growth (YoY) -- -- -237.7% -- -- --
EPS Growth (YoY) -- -- -250.0% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -- -53.8% -48.0% -42.0% -32.4% -28.4%
Return on Assets (ROA) -63.1% -56.3% -54.9% -49.0% -44.8% -39.7% -30.8% -26.9%
Current Ratio 7.43x 8.42x 10.28x 10.25x 10.45x 9.83x 11.62x 13.53x
Quick Ratio 7.22x 8.23x 10.01x 10.01x 10.15x 9.46x 11.11x 13.02x
Debt to Equity -- -- -- 0.01x 0.00x 0.00x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001789972) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:33 UTC · Open in terminal